Erratum Regarding “Phosphate-Binding Agents in Adults With CKD: A Network Meta-analysis of Randomized Trials” (Am J Kidney Dis. 2016;68[5]:691-702)

Errata Erratum Regarding “Phosphate-Binding Agents in Adults With CKD: A Network Meta-analysis of Randomized Trials” (Am J Kidney Dis. 2016;68[5]:691-702) In the Original Investigation entitled “Phosphate-Binding Agents in Adults With CKD: A Network Meta-analysis of Randomized Trials” that appeared in the November 2016 issue of AJKD (Palmer et al, volume 68, issue 5, pages 691-702), there were wording errors in 2 sentences of the Results and 1 sentence of a figure legend. In particular, the second sentence of the “Adverse Effects: Nausea, Constipation, Diarrhea, Abdominal Pain” subsection of “Results” (page 695), which originally read “Lanthanum ranked as the treatment with the highest probability of causing nausea (Fig 3),” should have read “Colestilan ranked as the treatment with the highest probability of causing nausea (Fig 3).” In the same subsection, in the first full sentence on page 696, the second odds ratio should have been 3.04 instead of 3.03, and the upper bound of the 95% confidence interval for the third odds ratio should have been 5.75 instead of 7.53. The sentence in its corrected form follows: “Sevelamer increased constipation compared with calcium, lanthanum, and iron (ORs of 2.12 [95% CI, 1.01-4.45], 3.04 [95% CI, 1.31-7.02], and 3.15 [95% CI, 1.73-5.75]) and was ranked worst for this adverse effect (Fig 5).” In the legend to Figure 5, the example given to explain the upper part of the grid included the wrong odds ratio and 95% confidence interval. The sentence in its corrected form follows: “For example, sevelamer is associated with a lower odds of diarrhea than iron treatment (OR, 0.36; 95% CI, 0.15-0.84).”

Erratum Regarding “Kidney Injury and Repair Biomarkers in Marathon Runners” (Am J Kidney Dis. 2017;70[2]:252-261) The Original Investigation entitled “Kidney Injury and Repair Biomarkers in Marathon Runners” that appeared in the August 2017 issue of AJKD (Mansour et al, volume 70, issue 2, pages 252-261) contained an error in Table 3. Specifically, the values given for urine albumin-creatinine ratio were inadvertently given in milligrams of albumin per milligram of creatinine instead of milligrams of albumin per gram of creatinine, which were the units that were listed. In its corrected form, the row in question (with column headings provided for clarity) is as follows:

Conventional Biomarker

Day 0: Premarathon (n 5 22)

Day 1: Immediately Postmarathon (n 5 22a)

Day 2: Postmarathon (n 5 22)

Overall P b

Urine albumin-creatinine ratio, mg/g

9 [8-13]

20 [16-49]

7 [4-11]

,0.001

452

Am J Kidney Dis. 2017;70(3):452